Kevin Hascup Lab

    Overview

    Our laboratory takes a geroscience approach to understanding biological processes that contribute to the pathogenesis of Alzheimer’s disease. The long-term goals of our laboratory are to:

    1. identify nonpharmacological interventions that target insulin and glutamate signaling pathways that prevent or alleviate cognitive decline and
    2. elucidate their mechanisms of action in order to identify pharmacological targets for treating Alzheimer’s disease and related dementias.

    To address these goals, our laboratory has several ongoing research interests examining the contribution of body temperature, glutamatergic neurotransmission, and glucose homeostasis on cognitive decline in mouse models of Alzheimer’s disease as well as extended longevity. These parameters are assessed by using innovative whole animal and molecular biological techniques to measure in vivo neurotransmitter dynamics, cognitive performance, and metabolism.

    Current projects

    •    Neurotransmitter dysregulation in AD (NIH R01 AG057767)
    •    Cell senescence in aging and AD (NIH R01 AG061937)
    •    COVID-19 Infection on AD (NIH R01 AG061937-S3)
    •    Core body temperature on AD pathogenesis
    •    Model organism development for AD, aging, and COVID-19
    •    Cell senescence in epilepsy

    News

    Alzheimer's research

    Glutamate shows potential for identifying change from healthy aging to Alzheimer’s

    A new publication from Drs. Kevin Hascup and Erin Hascup research groups at the Smith Alzheimer’s Center at SIU Medicine shows the potential for using glutamate to develop therapies for those with Alzheimer’s disease and dementia.
    Oladele

    Meet Oladele (Dickson) Owasoyo

    Oladele (Dickson) Owasoyo, PhD, is the newest addition to the research team in the Hascup Labs.
    Jesse Britz

    Losing Sleep Over It: Researching the Link Between Alzheimer's and Circadian Disruption

    A pharmacology and neuroscience student at SIU School of Medicine, Jesse Britz, along with Shelley Tischkau, PhD, and the Smith Alzheimer's Center Hascup Labs, recently researched the link between

    Past Lab Team Members

    • Lindsay Alewelt
    • Matthew Cleveland, MD
    • MaKayla Cox
    • Nahayo Esperant-Hilaire, MD        
    • Tracy Evans, PhD
    • Patrick Fitzgerald, MD
    • Thomas Johnston
    • Nadeem Khan, MD
    • Abigail Levy, MD
    • Erik Lokaitis
    • Neha Mokhasi
    • Oladele Owasoyo, PhD
    • Collin Pauly
    • Teonna Piphus
    • Hannah Roberts
    • Lindsey Sime
    • Ernesto Solis, Jr., PhD
    • Aaron Sul, MD
    • Farah Tamizuddin, MD
    • Darrow Traylor
    • Niyant Vora
    • Bradley Vost, MD